$RZLT
Rezolute, Inc. Stock $rzlt

$rzlt Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-Q Financial Statement

#000114420413060274 Filed on November 12, 2013

Income Statement

Concept	2013 Q4	2013 Q3	2012 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$670.0K	$690.0K	$10.00K
YoY Change	-34.95%	6800.0%	0.0%
% of Gross Profit
Research & Development	$0.00	$0.00	$0.00
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$0.00
YoY Change
% of Gross Profit
Operating Expenses	$650.1K	$700.9K	$542.9K
YoY Change	30.01%	29.11%	5328.82%
Operating Profit	-$650.1K	-$700.9K	-$542.9K
YoY Change	30.01%	29.11%
Interest Expense	$623.3K	$164.8K	$104.9K
YoY Change	469.68%	57.12%
% of Operating Profit
Other Income/Expense, Net	-$1.169M	-$118.6K	-$87.97K
YoY Change	3020.31%	34.85%
Pretax Income	-$1.820M	-$820.0K	-$10.00K
YoY Change	58.26%	8100.0%	0.0%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$1.819M	-$819.5K	-$630.9K
YoY Change	238.34%	29.91%	6208.5%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.02	-$0.02
Diluted Earnings Per Share	-$14.00M	-$0.02	-$0.02
COMMON SHARES
Basic Shares Outstanding	40.00M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2013 Q4	2013 Q3	2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.140M	$0.00	$0.00
YoY Change
Cash & Equivalents	$1.140M	$0.00	$0.00
Short-Term Investments
Other Short-Term Assets	$13.97K	$50.22K
YoY Change
Inventory	$223.0K	$223.0K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$1.859M	$576.0K	$0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$280.0K	$280.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$286.7K	$287.5K	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$1.859M	$576.0K	$0.00
Total Long-Term Assets	$286.7K	$287.5K	$0.00
Total Assets	$2.146M	$863.6K	$0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$477.5K	$408.9K
YoY Change	2287.48%
Accrued Expenses	$600.0K	$470.0K	$20.00K
YoY Change	5900.0%	2250.0%
Deferred Revenue
YoY Change
Short-Term Debt	$3.730M	$3.730M	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.543M	$5.680M	$20.00K
YoY Change	32612.9%	28299.98%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.543M	$5.680M	$20.00K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$6.540M	$5.680M	$20.00K
YoY Change	32600.0%	28300.0%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$40.00K	$40.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.397M	-$4.816M	-$20.00K
YoY Change
Total Liabilities & Shareholders Equity	$2.146M	$863.6K	$0.00
YoY Change

Cashflow Statement

Concept	2013 Q4	2013 Q3	2012 Q3
OPERATING ACTIVITIES
Net Income	-$1.819M	-$819.5K	-$630.9K
YoY Change	238.34%	29.91%	6208.5%
Depreciation, Depletion And Amortization	$0.00	$0.00
YoY Change
Cash From Operating Activities	-$360.0K	$3.671K	-$345.0K
YoY Change	-51.35%	-101.06%	3350.39%
INVESTING ACTIVITIES
Capital Expenditures	$0.00		$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$10.00K	$0.00
YoY Change	-96.15%
Cash From Investing Activities	-$10.00K	-$3.454K	-$64.16K
YoY Change	-96.15%	-94.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.510M	$0.00	$675.0K
YoY Change	15.27%	-100.0%
NET CHANGE
Cash From Operating Activities	-360.0K	$3.671K	-$345.0K
Cash From Investing Activities	-10.00K	-$3.454K	-$64.16K
Cash From Financing Activities	1.510M	$0.00	$675.0K
Net Change In Cash	1.140M	$217.00	$265.8K
YoY Change	267.74%	-99.92%	-2758.06%
FREE CASH FLOW
Cash From Operating Activities	-$360.0K	$3.671K	-$345.0K
Capital Expenditures	$0.00		$0.00
Free Cash Flow	-$360.0K		-$345.0K
YoY Change	-51.35%		3350.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-819531	USD
CY2013Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q3	dei	Document Type DocumentType	10-Q
CY2013Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2013Q3	us-gaap	Other Assets Current OtherAssetsCurrent	50218	USD
CY2013Q2	us-gaap	Other Assets Current OtherAssetsCurrent	95469	USD
CY2013Q3	dei	Document Period End Date DocumentPeriodEndDate	2013-09-30
CY2013Q3	dei	Amendment Flag AmendmentFlag	false
CY2013Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2013Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40000000	shares
CY2013Q3	antb	Consulting Fees ConsultingFees	81274	USD
CY2012Q3	antb	Consulting Fees ConsultingFees	117641	USD
CY2013Q3	dei	Trading Symbol TradingSymbol	ANTB
CY2013Q3	dei	Entity Registrant Name EntityRegistrantName	AntriaBio, Inc.
CY2013Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001509261
CY2013Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2013Q3	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2013Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2013Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2013Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40000000	shares
CY2013Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40000000	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40000000	shares
CY2013Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40000000	shares
CY2013Q3	us-gaap	Cash Cash	744	USD
CY2013Q2	us-gaap	Cash Cash	527	USD
CY2013Q3	us-gaap	Notes Receivable Related Parties Current NotesReceivableRelatedPartiesCurrent	163829	USD
CY2013Q2	us-gaap	Notes Receivable Related Parties Current NotesReceivableRelatedPartiesCurrent	163829	USD
CY2013Q3	us-gaap	Interest Receivable Current InterestReceivableCurrent	6795	USD
CY2013Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	3341	USD
CY2013Q3	us-gaap	Inventory Net InventoryNet	223000	USD
CY2013Q2	us-gaap	Inventory Net InventoryNet	223000	USD
CY2013Q3	us-gaap	Related Party Transaction Due From To Related Party Current RelatedPartyTransactionDueFromToRelatedPartyCurrent	60919	USD
CY2013Q2	us-gaap	Related Party Transaction Due From To Related Party Current RelatedPartyTransactionDueFromToRelatedPartyCurrent	183346	USD
CY2013Q3	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	70529	USD
CY2013Q2	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	146037	USD
CY2013Q3	us-gaap	Assets Current AssetsCurrent	576034	USD
CY2013Q2	us-gaap	Assets Current AssetsCurrent	815549	USD
CY2013Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	275717	USD
CY2013Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	275717	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	11819	USD
CY2013Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M18D
CY2013Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	12705	USD
CY2013Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	287536	USD
CY2013Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	288422	USD
CY2013Q3	us-gaap	Assets Assets	863570	USD
CY2013Q2	us-gaap	Assets Assets	1103971	USD
CY2013Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	408884	USD
CY2013Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	188346	USD
CY2013Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	953701	USD
CY2013Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	807001	USD
CY2013Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3732500	USD
CY2013Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3732500	USD
CY2013Q3	us-gaap	Interest Payable Current InterestPayableCurrent	469884	USD
CY2013Q2	us-gaap	Interest Payable Current InterestPayableCurrent	380575	USD
CY2013Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	115026	USD
CY2013Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	157761	USD
CY2013Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5679995	USD
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5266183	USD
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q3	us-gaap	Common Stock Value CommonStockValue	40000	USD
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	40000	USD
CY2013Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3979576	USD
CY2013Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3814258	USD
CY2013Q3	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	8836001	USD
CY2013Q2	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	8016470	USD
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	-4816425	USD
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	-4162212	USD
CY2013Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	863570	USD
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1103971	USD
	antb	Consulting Fees ConsultingFees	981778	USD
CY2013Q3	antb	Payroll Expenses PayrollExpenses	358453	USD
CY2012Q3	antb	Payroll Expenses PayrollExpenses	200567	USD
	antb	Payroll Expenses PayrollExpenses	4994330	USD
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	USD
CY2012Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3494	USD
CY2013Q3	us-gaap	General Insurance Expense GeneralInsuranceExpense	44813	USD
CY2012Q3	us-gaap	General Insurance Expense GeneralInsuranceExpense	4241	USD
	us-gaap	General Insurance Expense GeneralInsuranceExpense	163683	USD
CY2013Q3	antb	Meals And Entertainment Expenses MealsAndEntertainmentExpenses	12027	USD
CY2012Q3	antb	Meals And Entertainment Expenses MealsAndEntertainmentExpenses	1642	USD
	antb	Meals And Entertainment Expenses MealsAndEntertainmentExpenses	41809	USD
CY2013Q3	us-gaap	Professional Fees ProfessionalFees	165649	USD
CY2012Q3	us-gaap	Professional Fees ProfessionalFees	154408	USD
	us-gaap	Professional Fees ProfessionalFees	968592	USD
CY2013Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	12862	USD
CY2012Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	15792	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	144814	USD
CY2013Q3	antb	Travel Expenses TravelExpenses	5456	USD
CY2012Q3	antb	Travel Expenses TravelExpenses	43580	USD
	antb	Travel Expenses TravelExpenses	244589	USD
CY2013Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	886	USD
CY2012Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1181	USD
CY2013Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19483	USD
CY2012Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5011	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	122769	USD
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	700903	USD
CY2012Q3	us-gaap	Operating Expenses OperatingExpenses	542882	USD
	us-gaap	Operating Expenses OperatingExpenses	7667039	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-700903	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-542882	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7667039	USD
CY2013Q3	antb	Interest Income InterestIncome	3454	USD
CY2012Q3	antb	Interest Income InterestIncome	16930	USD
	antb	Interest Income InterestIncome	141045	USD
CY2013Q3	us-gaap	Interest Expense InterestExpense	164817	USD
CY2012Q3	us-gaap	Interest Expense InterestExpense	104898	USD
	us-gaap	Interest Expense InterestExpense	1194981	USD
CY2013Q3	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	42735	USD
CY2012Q3	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	0	USD
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	-115026	USD
CY2013Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-118628	USD
CY2012Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-87968	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1168962	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-630850	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8836001	USD
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2013Q3	antb	Weighted Average Number Basic Shares Outstanding WeightedAverageNumberBasicSharesOutstanding	40000000	shares
CY2012Q3	antb	Weighted Average Number Basic Shares Outstanding WeightedAverageNumberBasicSharesOutstanding	35284000	shares
	antb	Weighted Average Number Basic Shares Outstanding WeightedAverageNumberBasicSharesOutstanding	36161902	shares
CY2013Q3	antb	Weighted Average Number Diluted Shares Outstanding WeightedAverageNumberDilutedSharesOutstanding	40000000	shares
CY2012Q3	antb	Weighted Average Number Diluted Shares Outstanding WeightedAverageNumberDilutedSharesOutstanding	35284000	shares
	antb	Weighted Average Number Diluted Shares Outstanding WeightedAverageNumberDilutedSharesOutstanding	36161902	shares
CY2010Q1	us-gaap	Stockholders Equity StockholdersEquity	100	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
	us-gaap	Net Income Loss NetIncomeLoss	-505630	USD
CY2011Q2	us-gaap	Stockholders Equity StockholdersEquity	-505530	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-783383	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-6727457	USD
CY2012Q2	us-gaap	Stockholders Equity StockholdersEquity	-1288913	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3687502	USD
CY2013Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	165318	USD
CY2013	antb	Class Of Warrant Or Right Expense ClassOfWarrantOrRightExpense	191126	USD
CY2013	us-gaap	Stockholders Equity Note Spinoff Transaction StockholdersEquityNoteSpinoffTransaction	-24470	USD
CY2013Q3	us-gaap	Profit Loss ProfitLoss	-819531	USD
CY2012Q3	us-gaap	Profit Loss ProfitLoss	-630850	USD
	us-gaap	Profit Loss ProfitLoss	-8836001	USD
CY2013Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2012Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	10579	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	287500	USD
CY2013Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	75508	USD
CY2012Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	44786	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	437597	USD
CY2013Q3	us-gaap	Share Based Compensation ShareBasedCompensation	165318	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	409917	USD
CY2013Q3	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	146700	USD
CY2012Q3	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	0	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	951561	USD
CY2013Q3	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	89309	USD
CY2012Q3	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	49700	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	469884	USD
CY2013Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3671	USD
CY2012Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-345039	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2519915	USD
CY2013Q3	antb	Payment To Acquire Notes Receivable Related Parties PaymentToAcquireNotesReceivableRelatedParties	0	USD
CY2012Q3	antb	Payment To Acquire Notes Receivable Related Parties PaymentToAcquireNotesReceivableRelatedParties	0	USD
CY2012Q3	us-gaap	Share Based Compensation ShareBasedCompensation	0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3852820	USD
CY2013Q3	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-45251	USD
CY2012Q3	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	167	USD
CY2013Q3	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1	0	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	125218	USD
CY2013Q3	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-122427	USD
CY2012Q3	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	0	USD
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	84182	USD
CY2013Q3	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	220538	USD
CY2012Q3	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	180913	USD
CY2012Q3	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1	0	USD
	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1	11717	USD
CY2013Q3	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	0	USD
CY2012Q3	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	0	USD
	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	500000	USD
CY2013Q3	antb	Increase Decrease In Interest And Dividends Receivable Related Party IncreaseDecreaseInInterestAndDividendsReceivableRelatedParty	3454	USD
CY2012Q3	antb	Increase Decrease In Interest And Dividends Receivable Related Party IncreaseDecreaseInInterestAndDividendsReceivableRelatedParty	-19217	USD
	antb	Increase Decrease In Interest And Dividends Receivable Related Party IncreaseDecreaseInInterestAndDividendsReceivableRelatedParty	6795	USD
CY2013Q3	antb	Proceeds From Issuance Of Notes Receivable Related Party ProceedsFromIssuanceOfNotesReceivableRelatedParty	0	USD
CY2012Q3	antb	Proceeds From Issuance Of Notes Receivable Related Party ProceedsFromIssuanceOfNotesReceivableRelatedParty	-83372	USD
	antb	Proceeds From Issuance Of Notes Receivable Related Party ProceedsFromIssuanceOfNotesReceivableRelatedParty	-1138057	USD
	antb	Payment To Acquire Notes Receivable Related Parties PaymentToAcquireNotesReceivableRelatedParties	-974228	USD
CY2013Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3454	USD
CY2012Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-64155	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-682341	USD
CY2013Q3	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2012Q3	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	75000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	242000	USD
CY2013Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2012Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	750000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3480500	USD
CY2013Q3	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
CY2012Q3	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	35500	USD
CY2013Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
CY2012Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	675000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3203000	USD
CY2013Q3	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	217	USD
CY2012Q3	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	265806	USD
	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	744	USD
CY2012Q2	us-gaap	Cash Cash	25878	USD
CY2010Q1	us-gaap	Cash Cash	0	USD
CY2012Q3	us-gaap	Cash Cash	291684	USD
CY2013Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2012Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2013Q3	us-gaap	Interest Paid InterestPaid	0	USD
CY2012Q3	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Interest Paid InterestPaid	0	USD
CY2013Q3	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0	USD
CY2012Q3	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	1207	USD
CY2013Q3	antb	Assumption Of Related Party In Reverse Merger AssumptionOfRelatedPartyInReverseMerger	0	USD
CY2012Q3	antb	Assumption Of Related Party In Reverse Merger AssumptionOfRelatedPartyInReverseMerger	0	USD
	antb	Assumption Of Related Party In Reverse Merger AssumptionOfRelatedPartyInReverseMerger	23263	USD
CY2013Q3	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	0	USD
CY2012Q3	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Inventory Acquired1 NoncashOrPartNoncashAcquisitionInventoryAcquired1	223000	USD
CY2013Q3	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
CY2012Q3	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	264000	USD
CY2013Q3	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0	USD
	antb	Cash Paid For Asset Acquisition CashPaidForAssetAcquisition	500000	USD
CY2012Q3	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	13000	USD
CY2013Q3	antb	Cash Paid For Asset Acquisition CashPaidForAssetAcquisition	0	USD
CY2012Q3	antb	Cash Paid For Asset Acquisition CashPaidForAssetAcquisition	0	USD
CY2013Q1	us-gaap	Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued	35284000	shares
CY2013Q1	us-gaap	Business Acquisition Percentage Of Voting Interests Acquired BusinessAcquisitionPercentageOfVotingInterestsAcquired	0.882	pure
CY2013Q3	us-gaap	Use Of Estimates UseOfEstimates	<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Use of Estimates</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">  </font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt; COLOR: black">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts in the financial statements and the accompanying notes. Such estimates and assumptions impact, among others, the following: estimated useful lives and potential impairment of intangible assets, the fair value of share-based payments, estimates of the probability and potential magnitude of contingent liabilities and the valuation allowance for deferred tax assets due to continuing and expected future operating losses.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q1	antb	Business Acquisition Purchase Price Allocation Current Assets Inventory1 BusinessAcquisitionPurchasePriceAllocationCurrentAssetsInventory1	223000	USD
CY2013Q1	antb	Business Acquisition Purchase Price Allocation Fixed Assets BusinessAcquisitionPurchasePriceAllocationFixedAssets	264000	USD
CY2013Q1	antb	Business Acquisition Purchase Price Allocation Intangible Assets Other Than Goodwill1 BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwill1	13000	USD
CY2013Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	500000	USD
CY2013Q2	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	-157761	USD
CY2013Q3	antb	Fair Value Of Financial Instruments Earnings FairValueOfFinancialInstrumentsEarnings	42735	USD
CY2013Q3	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	-115026	USD
CY2013Q3	antb	Working Capital Deficit WorkingCapitalDeficit	5103961	USD
CY2013Q3	us-gaap	Line Of Credit Facility Amount Outstanding LineOfCreditFacilityAmountOutstanding	163829	USD
CY2013Q2	us-gaap	Line Of Credit Facility Amount Outstanding LineOfCreditFacilityAmountOutstanding	163829	USD
CY2013Q3	antb	Line Of Credit Facility Accrued Interest LineOfCreditFacilityAccruedInterest	6795	USD
CY2013Q2	antb	Line Of Credit Facility Accrued Interest LineOfCreditFacilityAccruedInterest	3341	USD
CY2012Q4	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.05	pure
CY2013Q3	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.0825	pure
CY2013Q3	antb	Related Party Expenses RelatedPartyExpenses	953701	USD
CY2013Q2	antb	Related Party Expenses RelatedPartyExpenses	807001	USD
CY2012Q3	antb	Consulting Expenses ConsultingExpenses	92651	USD
CY2011Q3	antb	Line Of Credit Issued To Related Party LineOfCreditIssuedToRelatedParty	1000000	USD
CY2013Q3	us-gaap	Line Of Credit Facility Interest Rate Description LineOfCreditFacilityInterestRateDescription	The line of credit bears interest equal to the lower of 10%, or the Wall Street Journal Prime Rate (3.25% at September 30, 2013), plus 5%.
CY2013Q3	antb	Consulting Expenses ConsultingExpenses	81274	USD
CY2013Q3	us-gaap	Due From Related Parties DueFromRelatedParties	60919	USD
CY2013Q2	us-gaap	Due From Related Parties DueFromRelatedParties	183346	USD
CY2013Q3	us-gaap	Line Of Credit Facility Description LineOfCreditFacilityDescription	The line of credit matured on August 31, 2012 and the Company has no further obligations to fund the credit line.
CY2013Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	3732500	USD
CY2010Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2011Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2013Q3	antb	Percentage Of Common Share Price Of Financing PercentageOfCommonSharePriceOfFinancing	0.65	pure
CY2013Q3	antb	Third Party Capital Investment ThirdPartyCapitalInvestment	2500000	USD
CY2011Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2011Q2	antb	Maximum Convertible Notes Payable Issuance MaximumConvertibleNotesPayableIssuance	2000000	USD
CY2011Q2	antb	Qualified Offering Common Stock QualifiedOfferingCommonStock	5000000	USD
CY2011Q2	antb	Percentage Of Common Share Price Of Financing PercentageOfCommonSharePriceOfFinancing	0.65	pure
CY2011Q2	antb	Maximum Conversion Pre Money Valuation MaximumConversionPreMoneyValuation	20000000	USD
CY2011Q2	antb	Percentage Of Exercise Per Share On Price Per Common Share PercentageOfExercisePerShareOnPricePerCommonShare	1.35	pure
CY2012Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2012Q3	antb	Maximum Convertible Notes Payable Issuance MaximumConvertibleNotesPayableIssuance	2000000	USD
CY2012Q3	antb	Percentage Of Price Per Common Share On Warrant To Purchase Two Shares Of Common Stock PercentageOfPricePerCommonShareOnWarrantToPurchaseTwoSharesOfCommonStock	1.35	pure
CY2012Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2012Q4	antb	Maximum Convertible Notes Payable Issuance MaximumConvertibleNotesPayableIssuance	1000000	USD
CY2012Q4	antb	Percentage Of Price Per Common Share On Warrant To Purchase One Share Of Common Stock PercentageOfPricePerCommonShareOnWarrantToPurchaseOneShareOfCommonStock	1.5	pure
CY2013Q3	antb	Convertible Notes Matured Amount ConvertibleNotesMaturedAmount	2907500	USD
CY2010	antb	Percentage Of Accrued Interest On Convertible Notes Payable PercentageOfAccruedInterestOnConvertibleNotesPayable	0.08	pure
CY2011	antb	Percentage Of Accrued Interest On Convertible Notes Payable PercentageOfAccruedInterestOnConvertibleNotesPayable	0.12	pure
CY2012Q4	antb	Description Of Convertible Notes DescriptionOfConvertibleNotes	On the date of a Qualified Financing, the lenders are permitted an elective conversion option to convert the outstanding principal and interest at the lower of 50% of the price per share of common stock in the Qualified Financing or $0.75 per share.
CY2012Q3	antb	Description Of Convertible Notes DescriptionOfConvertibleNotes	On the maturity date of the convertible notes, or the closing of a Sale of the Company, whichever occurs first, the lenders are permitted an elective conversion option to convert the outstanding principal and interest on the convertible notes at the lower of 65% of the price per share of common stock in the Qualified Financing or 65% of the common stock price using a pre-money valuation of the Company of $20 million.
CY2013Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	3732500	USD
CY2012Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1400000	shares
CY2012Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	248542	shares
CY2013Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	110000	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	9050000	shares
CY2013Q1	antb	Share Based Compensation Arrangement By Share Based Payment Award Options Shares Purchased Vested Immediately ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSharesPurchasedVestedImmediately	4916667	shares
CY2013Q1	antb	Share Based Compensation Arrangement By Share Based Payment Award Options Shares Purchased Vested Monthly ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSharesPurchasedVestedMonthly	3250000	shares
CY2013Q1	antb	Share Based Compensation Arrangement By Share Based Payment Award Options Shares Purchased Vested Monthly Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSharesPurchasedVestedMonthlyTerm	P3Y
CY2013Q2	antb	Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod	833333	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	50000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.75
CY2013Q2	antb	Share Based Compensation Arrangement By Share Based Payment Award Options Shares Purchased Vested Immediately ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsSharesPurchasedVestedImmediately	12500	shares
CY2013Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1517077	USD
CY2013Q3	antb	Class Of Warrant Value ClassOfWarrantValue	115026	USD
CY2013Q2	antb	Class Of Warrant Value ClassOfWarrantValue	157761	USD
CY2013Q3	antb	Fair Value Of Class Of Warrants FairValueOfClassOfWarrants	191126	USD
CY2011Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	9050000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9050000	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9050000	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6490974	shares
CY2011Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.75
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.75
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.75
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.75
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y7M6D
CY2013Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y3M18D
CY2012Q2	antb	Purchase Of Common Stock Shares Percentage PurchaseOfCommonStockSharesPercentage	0.05	pure
CY2012Q2	antb	Proceeds From Issuance Of Stock Option To Purchase Of Common Stock ProceedsFromIssuanceOfStockOptionToPurchaseOfCommonStock	3500000	shares

Files In Submission

Name	View Source	Status
0001144204-13-060274-index-headers.html	Edgar Link	pending
0001144204-13-060274-index.html	Edgar Link	pending
0001144204-13-060274.txt	Edgar Link	pending
0001144204-13-060274-xbrl.zip	Edgar Link	pending
antb-20130930.xml	Edgar Link	completed
antb-20130930.xsd	Edgar Link	pending
antb-20130930_cal.xml	Edgar Link	unprocessable
antb-20130930_def.xml	Edgar Link	unprocessable
antb-20130930_lab.xml	Edgar Link	unprocessable
antb-20130930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v358862_10q.htm	Edgar Link	pending
v358862_ex31-1.htm	Edgar Link	pending
v358862_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RZLT
Rezolute, Inc. Stock $rzlt

2013 Q4 Form 10-Q Financial Statement

#000114420413060274 Filed on November 12, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RZLT Rezolute, Inc. Stock $rzlt

2013 Q4 Form 10-Q Financial Statement

#000114420413060274 Filed on November 12, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RZLT
Rezolute, Inc. Stock $rzlt